L. Carter

CD8+ lymphocyte antiviral activity in monkeys immunized with SIV recombinant poxvirus vaccines: potential role in vaccine efficacy.

E. Paoletti, D. Venzon, J. Tartaglia, 1999, AIDS research and human retroviruses.

Vaccine Protection against a Heterologous, Non-Syncytium-Inducing, Primary Human Immunodeficiency Virus

S. Zolla-Pazner, M. Robert-Guroff, F. Sinangil, 1998, Journal of Virology.

Safety and immunogenicity of a SARS-CoV-2 recombinant protein nanoparticle vaccine (GBP510) adjuvanted with AS03: a phase 1/2, randomized, placebo-controlled, observer-blinded trial

Y. K. Kim, A. Walls, D. Veesler, 2022, medRxiv.